ubmslate-logo-ubm

P2 Mobile Logo

Search form

Topics:

Kenneth J. Bender, PharmD, MA

Kenneth J. Bender, PharmD, MA

Posts by Author

Cardiovascular risk/benefit profiles of pioglitazone and the SGLT2 inhibitor class are summarized, based on reports at ADA 2017.

A1C vs FPG to diagnose prediabetes; prediabetes and CHF; and how much weight loss is too much? Reports from ADA 2017.

When to start screening for B12 deficiency in your diabetes patients taking metformin? We review a dose-response diet study plus 2 others on oral drugs.

Insulin degludec vs glargine--which costs less per anum and why? We summarize this study and 2 other direct insulin comparisons reported at ADA 2017.

"Ladies and gentlemen of the jury," began the PAINWeek 2016 speaker, in mock trial defense of a physician for over-prescribing opioid meds.

A PAINWeek 2016 expert panel gave attendees behind-the-scenes insight into the process behind the CDC's final recommendations.

At PAINWeek 2016, a session on abuse-deterrent formulations underscored that this drug class will never be free from abuse potential.

A PAINWeek audience experienced behavioral Rx during a presentation on effective non-drug treatment for migraine.

This PAINWeek 2016 presentation focused on how to more deeply involve patients in their own pain management plan.

An overview of the largest study to examine persistent pulmonary hypertension in newborns (PPHN) exposed to antidepressants late in pregnancy.

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.